Liposomal formulation of gp41 derivative with adjuvant MPLA: Vaccine design, immunogenicity in animals and safety in humans

Karl Malcolm

Research output: Contribution to conference › Poster › peer-review

124 Downloads (Pure)
Original languageEnglish
Publication statusAccepted - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  • SDG 3 - Good Health and Well-being

Access to Document

    Cite this